Literature DB >> 61944

Specificity of serum from rodents immune to Moloney C-type virus-induced tumours.

N M Hogg.   

Abstract

When cells are infected by C-type viruses such as Moloney sarcoma/leukaemia virus, new antigens appear on the cell membrane. Mice and rats will respond immunologically to the antigen(s). It was uncertain whether the antigens were related to the viral structural proteins or to non-virion, tumour-specific surface antigens (TSSA) or both. In an 125I-antiglobulin binding assay, Moloney virus completely blocked the binding of mouse and rat sera to virus shedding target cells, thus suggesting that mice and rats recognise only viral proteins. Mice responded to type-specific and rats mainly to group-specific determinants on the virus. Individual Moloney viral proteins were prepared using the guanidine HCl method and were used to block the binding of the rat anti-Moloney immune serum to Moloney virus shedding target cells. By this method, it was demonstrated that the rat serum contains specificities for the viral proteins gp70 and p30, but it was not possible to detect any antibodies directed towards non-virion or TSSA-like molecules.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61944     DOI: 10.1002/ijc.2910180407

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens.

Authors:  E M Fenyo; E Yefenof; E Klein; G Klein
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

2.  Characterization of molecular species carrying gross cell surface antigen.

Authors:  H W Snyder; E Stockert; E Fleissner
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

3.  Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels.

Authors:  F A Troy; E M Fenyö; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.